Involvement of the HMGI(Y) gene in a microfollicular adenoma of the thyroid

Genes Chromosomes and Cancer

Volumn 24, Issue 3, 1999, Pages 286-289

  Dal Cin, Paola ^a   Fusco, Alfredo ^b   Belge, Gazanfer ^c   Chiappetta, Gennaro ^d   Fedele, Monica ^e   Pauwels, Patrick ^f   Bullerdiek, Jörn ^c   Van Den Berghe, Herman ^a,g  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF BREMEN   (Germany)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

^g CENTER FOR HUMAN GENETICS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CHROMOSOME 2; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; EPITHELIUM TUMOR; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID FUNCTION;

ADENOMA; ADULT; CHROMOSOME BANDING; HIGH MOBILITY GROUP PROTEINS; HMGA1A PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0032964552     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199903)24:3<286::AID-GCC16>3.0.CO;2-E     Document Type: Article

References (14)

1. Belge G, Bruckmann S, Thode B, Bartnitzke S, Bullerdiek J. 1996. Deletions of the short arm of chromosome 2 characterize a new cytogenetic subgroup of benign thyroid tumors. Genes Chromosomes Cancer 16:149-151.
2. Belge G, Roque L, Soares J, Bruckmann S, Thode B, Fonseca E, Clode A, Bartnitzke S, Castedo S, Bullerdiek J. 1998. Cytogenetic investigations of three hundred forty benign thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology. Cancer Genet Cytogenet 101:42-48.
3. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A. 1995. Inhibition of HMGIC protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 15:1545.
4. Bustin M, Reeves R. 1996. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucl Acid Res Mol Biol 54:35-100.
5. Chiappetta G, Bandiera A, Berlingiera MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V, Fusco A. 1995. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasia. Oncogene 10:1307-1314.
6. Fedele M, Bandiera A, Chiappetta G, Battista S, Viglietto G, Manfioletti G, Casamassimi A, Santoro M, Giancotti V, Fusco A. 1996. Human colorectal carcinomas express high levels of high mobility group HMGI (Y) proteins. Cancer Res 56:1896-1901.
7. Friedmann M, Holth LT, Zoghbi HY, Reeves R. 1993. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucl Acids Res 18:4259-4267.
8. Jackson DP, Quirke P, Lewis F, Boylston AW, Sloan JM, Robertson D, Taylor GR. 1989. Detection of measles virus RNA in paraffin-embedded tissue. Lancet 1:1391.
9. Kazmierczak B, Dal Cin P, Rogalla P, Van den Berghe H, Bullerdiek J. 1998a. The possible significance of HMG17 related breakpoints in human tumors: regional fine mapping of the human HMG17 gene to chromosomal band 1p35. Cancer Lett (submitted).
10. Kazmierczak B, Dal Cin P, Wanschura S, Borrmann L, Fusco A, Van den Berghe H, Bullerdiek J. 1998b. HMGI(Y) is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer 23:279-285.
11. Sambrook J, Fritsch E F, Maniatis T. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
12. Santoro M, Carlomagno F, Hay I D, Herrmann MA, Melillo RM, Bongarzone I, Pierotti MA, Della Porta G, Berger N, Peix JL, Paulin C, Fabien N, Grieco M, Vecchio G, Jenkins RB, Fusco A. 1992. RET oncogene activation in human thyroid neoplasms is restricted to the papillary carcinoma subtype. J Clin Invest 89:1517-1522.
13. Sozzi G, Miozzo M, Cariani TC, Bongarzone I, Pilotti S, Pierotti MA, Della Porta G. 1992. A t(2;3)(q12-13;p24-25) in follicular thyroid adenomas. Cancer Genet Cytogenet 64:38-41.
14. Tamimi Y, van der Poel HG, Denyn M, Umbas R, Karthaus HFM, Debruyne FMJ, Schalken JA. 1993. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res 53:5512-5516.